When tissue biopsy isn’t an option, obtain actionable molecular information for your patient’s cancer. Fast.
Understanding Liquid Biopsy
Biocept offers a simple blood test known as liquid biopsy that lets you establish approved, clinically actionable biomarker status for more personalized, responsive treatment.
A new option for learning about your patient’s cancer.
When cancer metastasizes or spreads, it sheds tumor cells and cancer-causing DNA fragments into the blood.
Biocept has developed the most advanced method for detecting and assessing tumor cells and cancer-causing DNA fragments in the blood.
You get the same information you would get from a tissue sample—from a simple blood test.
And because Biocept uses blood, you are informed about what’s happening with your patients’ cancer NOW—not weeks, months, or years ago.
When should you consider a liquid biopsy?
- Not enough tissue was obtained from an initial biopsy.
- Cancer starts in a place that is difficult to access for surgical biopsy.
- Cancer recurs after the initial tumor tissue has been removed.
- The patient is not responding to treatment as expected.
- The patient wishes to avoid additional biopsies.
How Does It Work?
Get Started With Liquid Biopsy
Contact Biocept today to learn how to get started. We can be reached by telephone at 858.320.8200 or by email at firstname.lastname@example.org.
Who Pays For a Liquid Biopsy?
Biocept accepts most insurance and will bill on behalf of the patient. In addition, Biocept has a Financial Assistance Program (see Billing Policy), with payment plans available based on the patient’s financial situation. We are committed to excellence and are here to assist with any questions or concerns you may have.
Please call 888.332.7410 M-F from 8-5 PST to discuss individual claims and policies.